In vitro pharmacological characterization of SPN-810M (molindone)

References

• JensenPSYoungstromEASteinerHConsensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studiesJ Am Acad Child Adolesc Psychiatry200746330932217314717
   PubMed Web of Science ®Google Scholar
• ConnorDFOn the challenge of maladaptive and impulsive aggression in the clinical treatment settingJ Child Adolesc Psychopharmacol20162612326835875
   PubMed Web of Science ®Google Scholar
• SaylorKEAmannBHImpulsive aggression as a comorbidity of attention-deficit/hyperactivity disorder in children and adolescentsJ Child Adolesc Psychopharmacol2016261192526744906
   PubMed Web of Science ®Google Scholar
• PliszkaSRCrismonMLHughesCWThe Texas Children’s Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry200645664265716721314
   PubMed Web of Science ®Google Scholar
• Scotto RosatoNCorrellCUPappadopulosETreatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing managementPediatrics20121296e1577158622641763
   PubMed Web of Science ®Google Scholar
• PappadopulosEMacintyreII JCCrismonMLTreatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part IIJ Am Acad Child Adolesc Psychiatry200342214516112544174
   PubMed Web of Science ®Google Scholar
• AdewoleTBrittainSTJohnsonJKLiransoTFindlingRLLong-term efficacy and safety of extended-release molindone (SPN-810) to manage impulsive aggression (IA) in children with attention deficit hyperactivity disorder (ADHD)Poster presented at: American Academy of Child and Adolescent PsychiatryOctober 24–29, 2016New York, NY
   Google Scholar
• BlairRJThe neurobiology of impulsive aggressionJ Child Adolesc Psychopharmacol20162614926465707
   PubMed Web of Science ®Google Scholar
• KraemerGWClarkeASSocial attachment, brain function, and aggressionAnn N Y Acad Sci19967941211358853599
   PubMed Web of Science ®Google Scholar
• KavoussiRArmsteadPCoccaroEThe neurobiology of impulsive aggressionPsychiatr Clin North Am19972023954039196921
   PubMed Web of Science ®Google Scholar
• SeoDPatrickCJKennealyPJRole of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disordersAggress Violent Behav200813538339519802333
   PubMed Web of Science ®Google Scholar
• LindgrenNUsielloAGoinyMDistinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sitesProc Natl Acad Sci U S A200310074305430912651945
   PubMed Web of Science ®Google Scholar
• UsielloABaikJHRougé-PontFDistinct functions of the two isoforms of dopamine D2 receptorsNature2000408680919920311089973
   PubMed Web of Science ®Google Scholar
• NarvaesRMartins de AlmeidaRMAggressive behavior and three neurotransmitters: dopamine, GABA, and serotonin—A review of the last 10 yearsPsychology & Neuroscience201474601607
   Google Scholar
• SakaueMAgoYSowaCModulation by 5-HT2A receptors of aggressive behavior in isolated miceJpn J Pharmacol2002891899212083749
   PubMedGoogle Scholar
• MarekGJCarpenterLLMcDougleCJPriceLHSynergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disordersNeuropsychopharmacology200328240241212589395
   PubMed Web of Science ®Google Scholar
• OwenRRJrColeJOMolindone hydrochloride: a review of laboratory and clinical findingsJ Clin Psychopharmacol1989;942682762671060
   PubMed Web of Science ®Google Scholar
• HayesGBidenTJSelbieLAShineJStructural subtypes of the dopamine D2 receptor are functionally distinct: expression of the cloned D2A and D2B subtypes in a heterologous cell lineMol Endocrinol1992669209261323056
   PubMedGoogle Scholar
• BonhausDWBachCDesouzaAThe pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptorsBr J Pharmacol199511546226287582481
   PubMed Web of Science ®Google Scholar
• SenoglesSESpiegelAMPadrellEIyengarRCaronMGSpecificity of receptor-G protein interactions. Discrimination of Gi subtypes by the D2 dopamine receptor in a reconstituted systemJ Biol Chem19902658450745142137824
   PubMed Web of Science ®Google Scholar
• BrittainSTStocksJDJohnsonJKLiransoTFindlingRLExtended-release molindone (SPN-810) as adjunctive therapy in the management of impulsive aggression in children with attention deficit hyperactivity disorder (ADHD) receiving optimized stimulant monotherapy and behavioral therapyPoster presented at: American Academy of Child and Adolescent PsychiatryOctober 26–31, 2015San Antonio, TX
   Google Scholar
• BrittainSTStocksJDJohnsonJKLiransoTFindlingRLAdjunctive extended-release molindone (SPN-810) to manage impulsive aggression in children with attention deficit hyperactivity disorder (ADHD) receiving optimized stimulant monotherapy and behavioral therapyPoster presented at: American Academy of NeurologyApril 15–21, 2016Vancouver, BC
   Google Scholar
• PolymeropoulosMHLicameleLVolpiSCommon effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophreniaSchizophr Res20091081–313414219150222
   PubMed Web of Science ®Google Scholar
• SikichLFrazierJAMcClellanJDouble-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) studyAm J Psychiatry2008165111420143118794207
   PubMed Web of Science ®Google Scholar
• SeemanPTallericoTAntipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptorsMol Psychiatry1998321231349577836
   PubMed Web of Science ®Google Scholar
• IchikawaJIshiiHBonaccorsoSFowlerWLO’LaughlinIAMelt-zerHY5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine releaseJ Neurochem20017651521153111238736
   PubMed Web of Science ®Google Scholar
• SeemanPAtypical antipsychotics: mechanism of actionCan J Psychiatry2002471273811873706
   PubMed Web of Science ®Google Scholar
• AmanMGVinksAARemmerieBPlasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disordersClin Ther20072971476148617825699
   PubMed Web of Science ®Google Scholar
• NeumeyerJLKulaNSBergmanJBaldessariniRJReceptor affinities of dopamine D1 receptor-selective novel phenylbenzazepinesEur J Pharmacol20034742–313714012921854
   PubMed Web of Science ®Google Scholar
• DodickDWMartinVTriptans and CNS side-effects: pharmacokinetic and metabolic mechanismsCephalalgia200424641742415154851
   PubMed Web of Science ®Google Scholar
• BalsaraJJGadaVPNandalNVChandorkarAGPsychopharmacological investigation of the monoamine oxidase inhibitory activity of molindone, a dihydroindolone neurolepticJ Pharm Pharmacol19843696086136149285
   PubMed Web of Science ®Google Scholar
• BladerJCPliszkaSRJensenPSSchoolerNRKafantarisVStimulant-responsive and stimulant-refractory aggressive behavior among children with ADHDPediatrics20101264e79680620837589
   PubMed Web of Science ®Google Scholar
• GurnaniTIvanovINewcornJHPharmacotherapy of aggression in child and adolescent psychiatric disordersJ Child Adolesc Psychopharmacol2016261657326881859
   PubMed Web of Science ®Google Scholar
• YanofskiJThe dopamine dilemma: using stimulants and antipsychotics concurrentlyPsychiatry2010761823
   Google Scholar
• ElbeDBarrAMHonerWGProcyshynRMManaging ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatmentJ Psychiatry Neurosci2014393E323324758945
   PubMed Web of Science ®Google Scholar
• MTA Cooperative GroupA 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorderArch Gen Psychiatry199956121073108610591283
   PubMed Web of Science ®Google Scholar
• AmanMGBinderCTurgayARisperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQJ Child Adolesc Psychopharmacol200414224325415319021
   PubMed Web of Science ®Google Scholar
• AuclairALCathalaASarrazinFThe central serotonin 2B receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activityJ Neurochem201011451323133220534001
   PubMed Web of Science ®Google Scholar
• De MeiCRamosMIitakaCBorrelliEGetting specialized: presynaptic and postsynaptic dopamine D2 receptorsCurr Opin Pharmacol200991535819138563
   PubMed Web of Science ®Google Scholar